EA
Emerald Advisers’s Treace Medical Concepts TMCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,561,893
| Closed | -$20.4M | – | 270 |
|
|
2024
Q1 | $20.4M | Buy |
1,561,893
+114,304
| +8% | +$1.49M | 0.82% | 49 |
|
|
2023
Q4 | $18.5M | Sell |
1,447,589
-25,692
| -2% | -$328K | 0.79% | 52 |
|
|
2023
Q3 | $19.3M | Buy |
1,473,281
+107,143
| +8% | +$1.4M | 0.94% | 41 |
|
|
2023
Q2 | $34.9M | Buy |
1,366,138
+2,685
| +0.2% | +$68.7K | 1.53% | 8 |
|
|
2023
Q1 | $34.3M | Buy |
1,363,453
+175,207
| +15% | +$4.41M | 1.65% | 7 |
|
|
2022
Q4 | $27.3M | Buy |
1,188,246
+67,481
| +6% | +$1.55M | 1.32% | 20 |
|
|
2022
Q3 | $24.7M | Buy |
1,120,765
+51,881
| +5% | +$1.15M | 1.28% | 22 |
|
|
2022
Q2 | $15.3M | Buy |
1,068,884
+196,605
| +23% | +$2.82M | 0.79% | 50 |
|
|
2022
Q1 | $16.5M | Buy |
872,279
+493,351
| +130% | +$9.33M | 0.63% | 66 |
|
|
2021
Q4 | $7.06M | Buy |
378,928
+107,051
| +39% | +$2M | 0.26% | 109 |
|
|
2021
Q3 | $7.31M | Buy |
271,877
+1,470
| +0.5% | +$39.5K | 0.27% | 108 |
|
|
2021
Q2 | $8.45M | Buy |
+270,407
| New | +$8.45M | 0.31% | 107 |
|